Obstetrics/Gynecology
RSSArticles
-
Menstrual Cups: Risk for IUD Expulsion?
In this case series from Colorado, seven women experienced IUD expulsion with menstrual cup removal.
-
Polycystic Ovary Syndrome: Etiology Likely Heterogeneous?
Rare noncoding variants of the gene DENND1A, previously shown to play a key role in androgen biosynthesis in human ovarian theca cells, are significantly associated with familial polycystic ovary syndrome.
-
Maternal Drug-Related Death and Suicide: Leading Causes of Postpartum Death in California
In a recent study, investigators found that drug-related death and suicide were leading causes of postpartum death in California.
-
Vaginal Bowel Control System for Nonsurgical Treatment of Fecal Incontinence
The vaginal bowel control device provides a safe, effective, and durable treatment option for women with fecal incontinence.
-
Many Teens Do Not Fill ED Prescriptions for STI Treatment
Results from a recent study of U.S. teens ages 13-19 show that when they are prescribed antibiotics for sexually transmitted infections during ED visits, some 60% fail to fill the prescriptions. The findings are a concern for providers, since adolescents represent nearly half of all diagnosed sexually transmitted infections annually.
-
The Push Is On to Reduce Pregnancy-Related Deaths
Pregnancy-related death can occur during pregnancy, delivery, and even up to one year after. National health experts are outlining ways to reduce maternal deaths in light of new research indicating that about three out of every five such deaths are preventable.
-
Telemedicine May Offer Access Option for Abortion
The TelAbortion study is designed to evaluate the use of telemedicine in providing medication abortion to women who have difficulty accessing abortion clinics.
-
Pharmacist-Prescribed Contraception Effective in Oregon
Study findings indicate that in the first two years after the Oregon law went into effect in 2016, pharmacist-prescribed contraception prevented more than 50 unintended pregnancies and saved an estimated $1.6 million in associated taxpayer costs.
-
Help Us Help You
Take our annual reader survey and tell us how we can better serve you.
-
New Progestin-Only Pill Receives FDA Approval
Women who are seeking an estrogen-free form of contraception now have a new option: Slynd, a drospirenone progestin-only pill. The pill is scheduled for release in fall 2019.